AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer
Teraneh Z. Jhaveri(Sidney Kimmel Cancer Center), Edward Gabrielson(Johns Hopkins University)
Cited by 43
Related Papers
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|897
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
|Nature Genetics|1995|646
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Research|2018|313
Molecular markers in ductal carcinoma in situ of the breast.
|PubMed|2003|261
A neural survival factor is a candidate oncogene in breast cancer
|Proceedings of the National Academy of Sciences|2003|132